Cleaning products maker Ecolab's Q3 sales beat on higher prices
Overview
Ecolab Q3 sales rose 4%, beating analyst expectations
Growth driven by Institutional & Specialty, Life Sciences segments
Outlook
Ecolab expects 2025 adjusted EPS between $7.48 and $7.58, up 12% to 14%
Company anticipates Q4 2025 adjusted EPS of $2.02 to $2.12, up 12% to 17%
Ecolab expects special charges of $0.34 per share in 2025, mainly for restructuring
Result Drivers
PRICING AND VOLUME GROWTH - Ecolab's Q3 results were driven by accelerating pricing from 2% to 3% and 1% volume growth, leading to strong EPS growth
SEGMENT PERFORMANCE - Institutional & Specialty, Pest Elimination, and Life Sciences segments led growth, with Global Water's Food & Beverage and Global High-Tech sectors offsetting declines in Basic Industries and Paper
OPERATING INCOME MARGIN - Ecolab's organic operating income margin expanded to 18.7%, supported by sales growth and productivity improvements, despite growth-oriented investments
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Beat | $4.17 bln | $4.12 bln (17 Analysts) |
Q3 Adjusted EPS | Meet | $2.07 | $2.07 (21 Analysts) |
Q3 EPS | $2.05 |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Ecolab Inc is $294.00, about 4.9% above its October 27 closing price of $279.71
The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 34 three months ago
Press Release:
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.